The Effect of Chinese Herbal Formula (KSY) on HCV Carrier With Abnormal Liver Function

Phase 2

Completed

• Conditions: Liver Function
• Interventions: Drug: KSY

• Registration Number: NCT01708733
• Lead Sponsor: Taipei City Hospital

Brief Summary

The aim of the study is to examine whether the Chinese herbal formula (KSY) is effective on HCV Carrier With Abnormal Liver Function.

Detailed Description

percentage of change on HCV RNA titer and liver function (GPT).

Study Timeline

• Study Start: 2012-08
• Study First Submitted: 2012-10-15
• Study First Submitted QC: 2012-10-15
• Study First Posted: 2012-10-17
• Primary Completion: 2014-01
• Study Completion: 2014-03
• Status Verified: 2014-05
• Last Update Submitted: 2014-05-28
• Last Update Posted: 2014-05-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 57

Inclusion Criteria

• 40 < GPT <200 HCV carrier Age: 18-65 yrs old

Exclusion Criteria

• Creatinine >2.0 mg/dL Total bilirubin > 2.0mg/dL Not suitable patients diagnosis by physician in charge.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
KSY	KSY	KSY, 100mg decoction by mouth per day for 6 weeks

Primary Outcome Measures

Name	Time	Method
HCV RNA titer	6 weeks

Secondary Outcome Measures

Name	Time	Method
Serum GPT level	6 weeks

Trial Locations

Locations (1)

Taipei City Hospital; 🇨🇳 Taipei, Taiwan